EMA Updates
The latest guidances, approvals, and safety alerts from EMA, curated by automated regulatory intelligence.
Schedules the Pharmacovigilance Risk Assessment Committee (PRAC) meeting cycle (23–26 November 2026) where it will assess medicines’ human-use risk management…
Addresses operational improvements to the EMA centralized procedure for human medicines, with a particular focus on implementing new EU pharmaceutical…
Strengthens the EMA’s ongoing engagement with general practitioners and key European GP organisations to support their continued participation in regulatory…
Establishes an EMA Quality Innovation Group (QIG) forum to exchange practical experiences on developing, implementing, and using digital and AI-enabled…
Operationalizes the EU Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) as an ongoing governance mechanism for crisis preparedness…
Role Management in CTIS is being trained through a dedicated live EMA session, including new Safety user roles introduced with the CTIS Safety Module.
Training on eXtended EudraVigilance Product Report Message (XEVPRM) and XEVMPDweb focuses on ensuring sponsors can submit and maintain mandatory medicinal…
Provides an in-person capacity-building training for EU candidate countries on how to apply the EU clinical trials regulatory framework in practice under the…
Workshop output on immunogenicity and efficacy evidence for pneumococcal vaccines, with emphasis on how evolving pneumococcal epidemiology and expanding…
Committee on Herbal Medicinal Products (HMPC) meeting schedules and role for preparing the Agency’s opinions on questions relating to herbal medicines.
Separates and updates the medically important (MI) VeDDRA terms list so it can be revised more flexibly, while positioning MI terms as a prioritisation lever…
Defines harmonised criteria for validating analytical methods used to generate residue depletion study data for veterinary drugs, covering key performance…
Outlines EMA CVMP data expectations for introducing a heat treatment step to inactivate endogenous retroviruses (e.g., RD114) in the production of live viral…
Clarifies how the EMA Product Management Service (PMS) enables access to human product data through the Product User Interface (PUI) and a read-only…
Transferable data exclusivity vouchers (TEVs) for priority antimicrobials would allow extension of regulatory data protection by 12 months, either for the…
Provides an EMA Q&A webinar forum on the XEVMPD service, aimed at resolving operational and procedural questions for stakeholders using XEVMPD across…
Advances the EU medicines regulatory network’s data and AI agenda by convening regulators and stakeholders to share progress and influence future policy…
Regulatory data management services at EMA will run a dedicated Q&A clinic to address questions on Substance, Organisation and Referentials (S,O,R) management…
Sets the remit for EMA’s Medicine Shortages Single Point of Contact (SPOC) Working Party to monitor and report EU events that may affect medicine supply…
Sets the schedule and agenda availability for the CVMP meeting on 3–5 November 2026, which is used to develop the Agency’s veterinary medicine opinions.